Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,287 | -56,701 | -29,494 | -18,900 | -13,988 |
| Depreciation Amortization | 4,257 | 2,699 | 1,234 | 1,138 | 680 |
| Income taxes - deferred | -21,743 | -15,769 | -7,797 | -6,482 | -4,568 |
| Accounts receivable | -3,388 | 2,181 | 2,534 | -13,012 | -8,581 |
| Accounts payable and accrued liabilities | 6,743 | 16,966 | 5,636 | 1,708 | 3,835 |
| Other Working Capital | 5,282 | 13,408 | -1,914 | -6,558 | -7,276 |
| Other Operating Activity | 8,111 | -11,183 | -3,346 | 26,349 | 15,958 |
| Operating Cash Flow | $-80,025 | $-48,399 | $-33,147 | $-15,757 | $-13,940 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -896 | -735 | -436 | -4,719 | -4,505 |
| Purchase Of Investment | -110,347 | -96,300 | -43,329 | -364,773 | -272,369 |
| Sale Of Investment | 161,237 | 125,667 | 87,667 | 352,062 | 255,451 |
| Investing Cash Flow | $49,994 | $28,632 | $43,902 | $-17,430 | $-21,423 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -1,351 | -834 | -409 | N/A | 0 |
| Debt Repayment | N/A | N/A | N/A | -155 | N/A |
| Other Financing Activity | -915 | -915 | -915 | 0 | 0 |
| Financing Cash Flow | $-2,266 | $-1,749 | $-1,324 | $-155 | $0 |
| Exchange Rate Effect | 3 | 183 | 49 | -163 | 39 |
| Beginning Cash Position | 102,785 | 102,785 | 102,785 | 136,290 | 136,290 |
| End Cash Position | 70,491 | 81,452 | 112,265 | 102,785 | 100,966 |
| Net Cash Flow | $-32,294 | $-21,333 | $9,480 | $-33,505 | $-35,324 |
| Free Cash Flow | |||||
| Operating Cash Flow | -80,025 | -48,399 | -33,147 | -15,757 | -13,940 |
| Capital Expenditure | -896 | -735 | -436 | -4,719 | -4,505 |
| Free Cash Flow | -80,921 | -49,134 | -33,583 | -20,476 | -18,445 |